Literature DB >> 30144151

Prognostic value of prior consolidation in acute myeloid leukemia patients undergoing hematopoietic cell transplantation in minimal residual disease-negative first complete remission.

Joan How1, Kiran R Vij2, Maryam Ebadi3, Todd E DeFor4, Rizwan Romee5, Michelle M Dolan6, Celalettin Ustun7, Daniel J Weisdorf7, Michael A Linden6, Armin Rashidi7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30144151      PMCID： PMC6239215          DOI： 10.1002/ajh.25262

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program.

Authors:  Michael Keeney; Jaimie G Halley; Daniel D Rhoads; M Qasim Ansari; Steven J Kussick; William J Karlon; Kumudini U Mehta; David M Dorfman; Michael A Linden
Journal:  Arch Pathol Lab Med       Date:  2015-02-19       Impact factor: 5.534

2.  History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission.

Authors:  Armin Rashidi; Michael A Linden; Todd E DeFor; Erica Warlick; Nelli Bejanyan; Sophia Yohe; Daniel J Weisdorf; Celalettin Ustun
Journal:  Am J Hematol       Date:  2017-07-29       Impact factor: 10.047

3.  Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.

Authors:  Betül Oran; Jeff L Jorgensen; David Marin; Sa Wang; Sairah Ahmed; Amin M Alousi; Borje S Andersson; Qaiser Bashir; Roland Bassett; Genevieve Lyons; Julianne Chen; Katy Rezvani; Uday Popat; Partow Kebriaei; Keyur Patel; Gabriela Rondon; Elizabeth J Shpall; Richard E Champlin
Journal:  Haematologica       Date:  2016-08-18       Impact factor: 9.941

4.  Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML.

Authors:  C Ustun; A C Wiseman; T E Defor; S Yohe; M A Linden; B Oran; M Burke; E Warlick; J S Miller; D Weisdorf
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

5.  Myeloablative, but not Reduced-Intensity, Conditioning Overcomes the Negative Effect of Flow-Cytometric Evidence of Leukemia in Acute Myeloid Leukemia.

Authors:  Celalettin Ustun; Elizabeth L Courville; Todd DeFor; Michelle Dolan; Nicole Randall; Sophia Yohe; Nelli Bejanyan; Erica Warlick; Claudio Brunstein; Daniel J Weisdorf; Michael A Linden
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-10       Impact factor: 5.742

6.  Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation.

Authors:  R B Walter; B Gyurkocza; B E Storer; C D Godwin; J M Pagel; S A Buckley; M L Sorror; B L Wood; R Storb; F R Appelbaum; B M Sandmaier
Journal:  Leukemia       Date:  2014-06-03       Impact factor: 11.528
  6 in total
  1 in total

1.  [Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].

Authors:  Y M Zhang; Y Zhang; X Ni; L Gao; H Y Qiu; Y S Zhang; G S Tang; J Chen; W P Zhang; J M Wang; J M Yang; X X Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.